Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Carnitine palmitoyltransferase I deficiency Indication Strategy Report 2026: CPT1A, Trials and Deals
30 July 2026
2026 Carnitine palmitoyltransferase I deficiency indication strategy covering epidemiology, CPT1A biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Carnitine-acylcarnitine translocase deficiency Indication Strategy Report 2026: SLC25A20, Trials and Deals
30 July 2026
2026 Carnitine-acylcarnitine translocase deficiency indication strategy covering epidemiology, SLC25A20 biology, active trials, transactions, unmet need,…
Latest Hotspot
8 min read
Trifunctional protein deficiency Indication Strategy Report 2026: HADHB, Trials and Deals
30 July 2026
2026 Trifunctional protein deficiency indication strategy covering epidemiology, HADHB biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Lactate dehydrogenase A deficiency Indication Strategy Report 2026: LDHA, Trials and Deals
30 July 2026
2026 Lactate dehydrogenase A deficiency indication strategy covering epidemiology, LDHA biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Short-chain acyl-CoA dehydrogenase deficiency Indication Strategy Report 2026: ACADS, Trials and Deals
30 July 2026
2026 Short-chain acyl-CoA dehydrogenase deficiency indication strategy covering epidemiology, ACADS biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Phosphoglycerate mutase deficiency Indication Strategy Report 2026: PGAM2, Trials and Deals
30 July 2026
2026 Phosphoglycerate mutase deficiency indication strategy covering epidemiology, PGAM2 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Phosphoglycerate kinase deficiency Indication Strategy Report 2026: PGK1, Trials and Deals
30 July 2026
2026 Phosphoglycerate kinase deficiency indication strategy covering epidemiology, PGK1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Aspartylglucosaminuria Indication Strategy Report 2026: AGA, Trials and Deals
30 July 2026
2026 Aspartylglucosaminuria indication strategy covering epidemiology, AGA biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Pompe disease infantile-onset Indication Strategy Report 2026: GAA, Trials and Deals
30 July 2026
2026 Pompe disease infantile-onset indication strategy covering epidemiology, GAA biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Sialidosis Indication Strategy Report 2026: NEU1, Trials and Deals
30 July 2026
2026 Sialidosis indication strategy covering epidemiology, NEU1 biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Multiple sulfatase deficiency Indication Strategy Report 2026: SUMF1, Trials and Deals
30 July 2026
2026 Multiple sulfatase deficiency indication strategy covering epidemiology, SUMF1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Megalencephalic leukoencephalopathy with subcortical cysts Indication Strategy Report 2026: MLC1, Trials and Deals
30 July 2026
2026 Megalencephalic leukoencephalopathy with subcortical cysts indication strategy covering epidemiology, MLC1 biology, active trials, transactions, unmet need,…